LAMISIL AT CREAM- terbinafine hydrochloride cream 
Karo Healthcare Inc.

----------

Lamisil AT (Terbinafine Hydrochloride) Cream 1% 30 g

Active Ingredient

Terbinafine hydrochloride 1%

Purpose

Antifungal

Uses

Warnings

For external use only

Do not use

  • on nails or scalp
  • in or near the mouth or eyes
  • for vaginal yeast infections

When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if too much irritation occurs or gets worse

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other Information

Inactive Ingredients

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol

Questions or comments?

call 1-888-544-1880

PACKAGE LABEL.PRINCIPAL DISPLAY

LAMISILAT
CREAM
TERBINAFINE HYDROCHLORIDE
CREAM 1% - ANTIFUNGAL

FOR ATHLETE'S FOOT

RELIEVES ITCHING

CLINICALLY PROVEN TO CURE MOST ATHLETE’S FOOT BETWEEN THE TOES

FULL PRESCRIPTION STRENGTH


NET WT 30 g (1 oz)

RECYCLABLE CARTON

Distributed by: Karo Healthcare Inc.
Morristown, NJ 07960 USA

Made in Canada

Trademarks owned or licensed
by Karo Healthcare

©2024 Karo Healthcare
or licensor.

1-888-544-1880

NDC
84485-3748-3
2004439_1

Vertical Carton

2003665_1

Horizontal Carton

LAMISILAT CREAM
TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL
FOR ATHLETE'S FOOT

NET WT
30g (1 oz)

2004440_1

Label
LAMISIL AT CREAM 
terbinafine hydrochloride cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84485-3748
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE1 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
CETYL ALCOHOL (UNII: 936JST6JCN)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CETYL PALMITATE (UNII: 5ZA2S6B08X)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
WATER (UNII: 059QF0KO0R)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:84485-3748-31 in 1 CARTON11/01/2024
130 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02098011/01/2024
Labeler - Karo Healthcare Inc. (119195452)

Revised: 1/2025
Document Id: 58726dc3-45ee-4543-8863-3949940fb64e
Set id: 7f8434c2-60c9-4aeb-b0b8-f69107e74609
Version: 2
Effective Time: 20250109
 
Karo Healthcare Inc.